Weil Company’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.21M Sell
16,501
-4,239
-20% -$625K 0.39% 47
2026
Q1
$2.98M Sell
20,740
-781
-4% -$128K 0.67% 35
2025
Q4
$3.75M Sell
21,521
-1,761
-8% -$323K 0.86% 32
2025
Q3
$4.78M Sell
23,282
-197
-0.8% -$38.6K 1.15% 22
2025
Q2
$4.23M Sell
23,479
-1,649
-7% -$277K 1.11% 24
2025
Q1
$4.06M Buy
25,128
+420
+2% +$72.1K 1.21% 23
2024
Q4
$4.29M Sell
24,708
-10,080
-29% -$1.78M 1.48% 19
2024
Q3
$5.5M Sell
34,788
-4,789
-12% -$715K 1.8% 14
2024
Q2
$5.34M Buy
39,577
+5,081
+15% +$665K 1.95% 15
2024
Q1
$4.42M Buy
34,496
+4,123
+14% +$510K 1.75% 15
2023
Q4
$3.64M Sell
30,373
-5,658
-16% -$613K 1.6% 19
2023
Q3
$3.86M Sell
36,031
-1,450
-4% -$150K 1.92% 10
2023
Q2
$3.68M Sell
37,481
-196
-0.5% -$17.7K 1.64% 14
2023
Q1
$3.3M Sell
37,677
-2,040
-5% -$192K 1.5% 15
2022
Q4
$3.46M Sell
39,717
-810
-2% -$72.8K 1.58% 15
2022
Q3
$3.06M Buy
40,527
+816
+2% +$66.1K 1.88% 10
2022
Q2
$3.13M Buy
39,711
+5,176
+15% +$433K 1.76% 11
2022
Q1
$3.03M Sell
34,535
-21,124
-38% -$2.17M 1.52% 13
2021
Q4
$5.76M Sell
55,659
-8,677
-13% -$926K 2.69% 5
2021
Q3
$5.92M Sell
64,336
-10,621
-14% -$931K 3.08% 4
2021
Q2
$6.13M Buy
74,957
+3,099
+4% +$224K 3.1% 4
2021
Q1
$4.78M Buy
71,858
+1,101
+2% +$74.3K 2.71% 7
2020
Q4
$4.76M Sell
70,757
-10,344
-13% -$670K 2.85% 7
2020
Q3
$4.79M Buy
81,101
+10,990
+16% +$630K 3.49% 6
2020
Q2
$3.9M Buy
70,111
+2,316
+3% +$135K 3.3% 6
2020
Q1
$3.53M Buy
67,795
+36,685
+118% +$1.9M 3.32% 5
2019
Q4
$1.52M Buy
31,110
+5,746
+23% +$271K 1.16% 26
2019
Q3
$1.14M Buy
25,364
+7,102
+39% +$315K 0.85% 28
2019
Q2
$813K Buy
18,262
+2,600
+17% +$121K 0.66% 35
2019
Q1
$718K Sell
15,662
-1,700
-10% -$75K 0.6% 42
2018
Q4
$639K Buy
+17,362
New +$708K 0.58% 40

Other funds holding HLI

Weil Company's HLI Position: Q2 2026 in Review

Weil Company reduced its Houlihan Lokey (HLI) stake by 20% in Q2 2026, selling an estimated $625K and leaving 16,501 shares worth $2.21M. The position accounts for 0.39% of the portfolio, ranked #47.

Weil Company first reported a position in HLI in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.13M in Q2 2021. 514 funds tracked by Wall St. Rank hold HLI as of Q2 2026.

  • Weil Company held 16,501 shares of Houlihan Lokey worth $2.21M as of Q2 2026.
  • Weil Company sold 4,239 Houlihan Lokey shares in Q2 2026, an estimated $625K.
  • Houlihan Lokey made up 0.39% of Weil Company's portfolio in Q2 2026, its #47 holding.
  • Weil Company first reported a position in Houlihan Lokey in Q4 2018 and has held it in 31 quarters since.
  • Weil Company's Houlihan Lokey position peaked at $6.13M in Q2 2021.
  • 514 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.

Based on Weil Company's 13F filing for Q2 2026, filed 5 Aug 2026.